Teza Capital Management LLC cut its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 81.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,135 shares of the company's stock after selling 4,931 shares during the quarter. Teza Capital Management LLC's holdings in HCA Healthcare were worth $392,000 at the end of the most recent quarter.
Several other large investors have also modified their holdings of HCA. Brighton Jones LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $1,021,000. Cary Street Partners Financial LLC purchased a new position in shares of HCA Healthcare during the fourth quarter valued at approximately $187,000. Cetera Investment Advisers lifted its stake in shares of HCA Healthcare by 21.6% during the fourth quarter. Cetera Investment Advisers now owns 29,171 shares of the company's stock valued at $8,756,000 after buying an additional 5,187 shares during the period. Humankind Investments LLC lifted its stake in shares of HCA Healthcare by 15.3% during the fourth quarter. Humankind Investments LLC now owns 4,317 shares of the company's stock valued at $1,296,000 after buying an additional 573 shares during the period. Finally, Janus Henderson Group PLC lifted its stake in shares of HCA Healthcare by 14.9% during the fourth quarter. Janus Henderson Group PLC now owns 1,538,826 shares of the company's stock valued at $461,883,000 after buying an additional 199,188 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on the stock. Wolfe Research downgraded shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Wells Fargo & Company cut their price target on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 14th. Robert W. Baird increased their price target on shares of HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. Royal Bank Of Canada cut their price target on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research note on Monday, July 28th. Finally, Truist Financial increased their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research note on Wednesday, July 16th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average price target of $403.17.
View Our Latest Analysis on HCA
Insiders Place Their Bets
In related news, EVP Michael S. Cuffe sold 3,836 shares of the firm's stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.30% of the company's stock.
HCA Healthcare Trading Up 0.7%
Shares of HCA Healthcare stock traded up $2.69 during trading hours on Friday, hitting $405.54. The company's stock had a trading volume of 761,184 shares, compared to its average volume of 1,129,364. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $420.98. The business has a fifty day moving average of $382.88 and a 200 day moving average of $363.07. The company has a market capitalization of $94.89 billion, a PE ratio of 17.05, a P/E/G ratio of 1.27 and a beta of 1.41. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same quarter in the prior year, the business earned $5.50 earnings per share. The business's quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.
HCA Healthcare Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.